1. Home
  2. GBX vs EVO Comparison

GBX vs EVO Comparison

Compare GBX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$46.46

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBX
EVO
Founded
1974
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GBX
EVO
Price
$46.46
$3.13
Analyst Decision
Sell
Strong Buy
Analyst Count
3
1
Target Price
$50.67
$7.00
AVG Volume (30 Days)
334.5K
269.8K
Earning Date
01-08-2026
11-05-2025
Dividend Yield
2.75%
N/A
EPS Growth
27.96
N/A
EPS
6.35
N/A
Revenue
$3,240,200,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.80
P/E Ratio
$7.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.77
$2.84
52 Week High
$71.06
$5.10

Technical Indicators

Market Signals
Indicator
GBX
EVO
Relative Strength Index (RSI) 58.21 50.69
Support Level $46.02 $2.87
Resistance Level $47.03 $3.05
Average True Range (ATR) 1.02 0.10
MACD -0.07 0.03
Stochastic Oscillator 41.90 72.97

Price Performance

Historical Comparison
GBX
EVO

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: